Research graph
References from Rapid and reproducible karyotyping with long-read sequencing in patients with AML. Local targets link to admitted publications; unresolved targets remain external evidence.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
10.1182/blood-2016-03-643544 · 2016 · External reference
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial
10.1016/s2352-3026(21)00134-4 · 2021 · External reference
CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia
10.1200/jco.2017.77.6112 · 2018 · External reference
International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data
10.1182/blood.2022015850 · 2022 · External reference
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
10.1182/blood.2022016867 · 2022 · External reference
The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
10.1038/s41375-022-01613-1 · 2022 · External reference
Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities
10.1038/gim.2016.50 · 2016 · External reference
The need for rapid cytogenetics in the era of unique therapies for acute myeloid leukemia
10.1182/bloodadvances.2022008000 · 2022 · External reference
Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML
10.1182/bloodadvances.2020002517 · 2021 · External reference
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing
10.3324/haematol.2018.194258 · 2019 · External reference
Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers
10.1056/nejmoa2024534 · 2021 · External reference
Oxford nanopore MinION sequencing and genome assembly
10.1016/j.gpb.2016.05.004 · 2016 · External reference
10.1016/j.csbj.2021.07.030 · 2021 · Admitted local publication
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
10.1007/s00277-017-3150-3 · 2017 · External reference
Unresolved reference
2020 · External reference
Measurable residual disease (MRD) monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
10.1182/blood-2018-02-829911 · 2018 · External reference
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
10.1182/bloodadvances.2021004367 · 2021 · External reference
Accurate detection of complex structural variations using single-molecule sequencing
10.1038/s41592-018-0001-7 · 2018 · External reference
The clinical utility of optical genome mapping for the assessment of genomic aberrations in acute lymphoblastic leukemia
10.3390/cancers13174388 · 2021 · External reference
Integrative genomics viewer
10.1038/nbt.1754 · 2011 · External reference
ACE: absolute copy number estimation from low-coverage whole-genome sequencing data
10.1093/bioinformatics/bty1055 · 2019 · External reference
CyDAS: a cytogenetic data analysis system
10.1093/bioinformatics/bti146 · 2005 · External reference
Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype
10.1200/jco.2008.16.0259 · 2008 · External reference
Evaluation of tools for identifying large copy number variations from ultra-low-coverage whole-genome sequencing data
10.1186/s12864-021-07686-z · 2021 · External reference
Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia
10.1038/s41408-024-01108-5 · 2024 · External reference
Comparative analysis of two NGS-based platforms for product-of-conception karyotyping
10.3390/genes15081100 · 2024 · External reference
Optical genome mapping as a diagnostic tool in pediatric acute myeloid leukemia
10.3390/cancers14092058 · 2022 · External reference
Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AML
10.1038/s41698-025-01258-0 · 2026 · External reference
CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data
10.1186/s12859-016-1174-7 · 2016 · External reference
Tumor ploidy determination in low-pass whole genome sequencing and allelic copy number visualization using the Constellation Plot
10.1186/s13059-025-03599-2 · 2025 · External reference
Real-time genomic characterization of pediatric acute leukemia using adaptive sampling
10.1038/s41375-025-02565-y · 2025 · External reference
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
10.1182/blood.2025031480 · 2025 · External reference
Impact of cytogenetic response to therapy on long-term survival in acute myeloid leukemia
10.1002/ajh.70000 · 2025 · External reference
